Waiver of patent on COVID vaccine: re-packaging of TRIPS flexibilities
by Mariya Fatma; P.R.L. Rajavenkatesan
International Journal of Intellectual Property Management (IJIPM), Vol. 13, No. 3/4, 2023

Abstract: Innovation, research, and development are important for the development of a society and country, and thus there is a need to protect and encourage these inventions. Patent law provides the perfect tool for incentivising such research. Every country has a different standard of granting protection, and the TRIPS Agreement provides a uniform minimum standard of patent protection in all technology fields. And for the first time since its enforcement after TRIPS enforcement, these standards were compromised in a mutual decision by the WTO in the wake of public health. The article discusses the need for patent law and its importance in providing access to medicine. It also discusses the flexibilities in the TRIPS Agreement and DOHA Declaration for balancing the interests of private parties, i.e., the patent holder and the general public's right to health. The article further analyses the recent decision of the WTO Ministerial Council taken on the TRIPS Agreement about the waiver of patent rights and how such a waiver will be efficient, keeping in mind the proposed effect of this waiver in the wake of the current circumstances.

Online publication date: Tue, 10-Oct-2023

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com